Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.

SS Innovations International, an Indian surgical robotics company, is set to list on the Nasdaq under the ticker 'SSII' on ...

Novavax Inc. research and ratings by Barron's. View NVAX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

The US stock market has been flirting with a bear market recently, but has yet to cross the Rubicon. Click to read.

Viking TherapeuticsVKTX reported a first-quarter 2025 loss of 41 cents per share, wider than the Zacks Consensus Estimate of ...

INVO Fertility (IVF), formerly known as NAYA Biosciences (NAYA), confirmed it will begin trading under the new symbol “IVF” at the market open ...

A clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies.

UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, April 23: Casella ...

Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...